Artificial Intelligence in Modern Healthcare: Advances in Drug Repurposing, Mental Health Monitoring and Clinical Decision Support Systems
DOI:
https://doi.org/10.69996/jsihs.2026001Keywords:
Artificial Intelligence, Healthcare, Clinical Decision, Drug RepurposingAbstract
The integration of computational intelligence in modern healthcare has ushered in transformative advancements across various domains, significantly enhancing diagnosis, treatment, and patient care. This review explores recent progress in three critical areas: drug repurposing, mental health monitoring, and clinical decision support systems. Drug repurposing leverages large-scale biological and chemical data to identify new therapeutic applications for existing medications, offering a faster and costeffective pathway to treatment development. In the realm of mental health, digital tools combined with physiological and behavioral data are being used to detect early symptoms, monitor patient progress, and personalize therapeutic interventions. Furthermore, clinical decision support systems are playing a vital role in assisting healthcare professionals by synthesizing patient history, laboratory results, and medical guidelines to recommend accurate and timely interventions. These systems not only reduce diagnostic errors but also improve workflow efficiency and patient outcomes. The review critically examines key methodologies, practical implementations, and real-world applications, while also addressing ethical challenges, data privacy concerns, and regulatory considerations. By synthesizing current research and healthcare practices, this article aims to provide a comprehensive overview of how advanced computational techniques are reshaping the delivery of healthcare services.
References
[1] S. Iyanna, P.Kaur, P. Ractham, S. Talwar and A.N. Islam, “Digital transformation of healthcare sector. What is impeding adoption and continued usage of technology-driven innovations by end-users?,” Journal of Business Research, vol.153, pp.150-161, 2022.
[2] M. Rudrapal, S.J. Khairnar and A.G. Jadhav, “Drug repurposing (DR): An emerging approach in drug. Drug repurposing: Hypothesis, molecular aspects and therapeutic applications,” Hamburg, Germany: Books on Demand, pp.3-22, 2020.
[3] S. Quazi, “Artificial intelligence and machine learning in precision and genomic medicine,” Medical Oncology, vol.39, no.8, pp.120, 2022.
[4] A. Fakih, “The Effect of Clinical Decision Support Tools on Physicians’ Practices,” The Journal of the Association of Physicians of India, vol.73, no.2, pp.26-30, 2025.
[5] K.K. Vaigandla, “A Systematic Survey on Artificial Intelligence in 6G Wireless Networks: Security, Opportunities, Applications, Advantages, Future Research Directions and Challenges,” Babylonian Journal of Artificial Intelligence, vol.2025, pp.99-106, 2025.
[6] P. Hamet and J. Tremblay, “Artificial intelligence in medicine,” Metabolism, vol.69, pp.S36-S40, 2017.
[7] K.K. Vaigandla, R. Karne, M.K. Vanteru, M. Devsingh, D. Prasad, R.K. Siddoju and N. Dharavath, “Artificial Intelligence in Industrial IoT: Trends, Challenges, and Future Directions,” Journal of Computer Allied Intelligence, vol.3, no.2, pp.37-55, 2025.
[8] H. Sheikh, C. Prins and E. Schrijvers, “Artificial intelligence: definition and background,” In Mission AI: The new system technology, pp. 15-41, 2023.
[9] V. Yashchenko, “Artificial intelligence theory (Basic concepts),” In 2014 Science and Information Conference, pp. 473-480, 2014.
[10] A. Valavanidis, “Artificial intelligence (ai) applications,” Department of Chemistry, National and Kapodistrian University of Athens, University Campus Zografou, vol.15784, 2023.
[11] Y. Lu, “Artificial intelligence: a survey on evolution, models, applications and future trends,” Journal of management analytics, vol.6, no.1, pp.1-29, 2019.
[12] I. Celik, M. Dindar, H. Muukkonen and S. Järvelä, “The promises and challenges of artificial intelligence for teachers: A systematic review of research,” Tech Trends, vol.66, no.4, pp.616-630, 2022.
[13] S. Mohanty, M.H.A. Rashid, M. Mridul, C. Mohanty and S. Swayamsiddha, “Application of Artificial Intelligence in COVID-19 drug repurposing,” Diabetes and Metabolic Syndrome: Clinical Research and Reviews, vol.14, no.5, pp.1027-1031, 2022.
[14] S. Quazi, “Role of artificial intelligence and machine learning in bioinformatics: Drug discovery and drug repurposing,” The Lancet Digital Health, 2021.
[15] Y. Zhou, F. Wang, J. Tang, R. Nussinov and F. Cheng, “Artificial intelligence in COVID19 drug repurposing,” The Lancet Digital Health, vol.2, no.12, pp.e667-e676, 2020.
[16] H. Farghali, N.K. Canová and M. Arora, “The potential applications of artificial intelligence in drug discovery and development,” Physiological Research, vol.70, no.Suppl 4, pp.S715, 2021.
[17] M. Aljofan and A. Gaipov, “Drug discovery and development: the role of artificial intelligence in drug repurposing,” Future Medicinal Chemistry, vol.16, no.7, pp.583-585, 2024.
[18] X. Li, J.F. Rousseau, Y. Ding, M. Song and W. Lu, “Understanding drug repurposing from the perspective of biomedical entities and their evolution: Bibliographic research using aspirin,” JMIR medical informatics, vol.8, no.6, pp.e16739, 2020.
[19] K. Park, “A review of computational drug repurposing,” Translational and clinical pharmacology, vol.27, no.2, pp.59, 2019.
[20] Y. Ni and F. Jia, “A scoping review of AI-Driven digital interventions in mental health care: mapping applications across screening, support, monitoring, prevention, and clinical education,” In Healthcare, vol. 13, no. 10, pp. 1205, 2025.
[21] R. Ajayi, “AI-powered innovations for managing complex mental health conditions and addiction treatments,” International Research Journal of Modernization in Engineering Technology and Science, pp.1-18, 2025.
[22] T. Shaik, X. Tao, N. Higgins, H. Xie, R. Gururajan and X. Zhou, “AI enabled RPM for mental health facility,” In Proceedings of the 1st ACM Workshop on Mobile and Wireless Sensing for Smart Healthcare, pp. 26-32, 2022.
[23] E.A. Paraschiv, L. Băjenaru, C. Petrache, O. Bica and D.N. Nicolau, “AI-driven neuromonitoring: advancing schizophrenia detection and management through deep learning and EEG analysis,” Future Internet, vol.16, no.11, pp.424, 2024.
[24] D. Karimzadeh and A. Saeedi, “AI for Mental Health Assessment and Intervention: A Systematic Review,” International journal of Modern Achievement in Science, Engineering and Technology, vol.2, no.1, pp.96-104, 2024.
[25] D.A. Regier, C.T. Kaelber, D.S. Rae, M.E. Farmer, B. Knauper, R.C. Kessler and G.S. Norquist, “Limitations of diagnostic criteria and assessment instruments for mental disorders: implications for research and policy,” Archives of general psychiatry, vol.55, no.2, pp.109-115, 1998.
[26] R.D. Handy and M.H. Depledge, “Physiological responses: their measurement and use as environmental biomarkers in ecotoxicology,” Ecotoxicology, vol.8, no.5, pp.329-349, 1999.
[27] S. Basheer, A.S. Alluhaidan and M.A. Bivi, “Real-time monitoring system for early prediction of heart disease using Internet of Things,” Soft Computing, vol.25, no.18, pp.12145-12158, 2021.
[28] M. Elhaddad and S. Hamam, “AI-driven clinical decision support systems: an ongoing pursuit of potential,” Cureus, vol.16, no.4, 2024.
[29] L. Wang, X. Chen, L. Zhang, L. Li, Y. Huang, Y. Sun and X. Yuan, “Artificial intelligence in clinical decision support systems for oncology,” International Journal of Medical Sciences, vol.20, no.1, pp.79, 2023.
[30] W.C. Juang, M.H. Hsu, Z.X. Cai and C.M. Chen, “Developing an AI-assisted clinical decision support system to enhance in-patient holistic health care,” Plos one, vol.17, no.10, pp.e0276501, 2022.
[31] E.S. Berner and T.J. La Lande, “Overview of clinical decision support systems,” In Clinical decision support systems: Theory and practice, pp. 1-17, 2016.
[32] J.D. Mujumdar and H. Jeffcoat, “How Clinical Decision Support Tools Can Be Used to Support Modern Care Delivery,” facs. org/clincon, vol.2022, no.20, 2022.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Journal of Sensors, IoT & Health Sciences (JSIHS,ISSN: 2584-2560)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Fringe Global Scientific Press publishes all the papers under a Creative Commons Attribution-Non-Commercial 4.0 International (CC BY-NC 4.0) (https://creativecommons.org/licenses/by-nc/4.0/) license. Authors have the liberty to replicate and distribute their work. Authors have the ability to use either the whole or a portion of their piece in compilations or other publications that include their own work. Please see the licensing terms for more information on reusing the work.
